Sten Gunnar Otto Skolling

Sten Gunnar Otto Skolling

Director/Board Member chez CHORDATE MEDICAL HOLDING AB

62 ans
Health Technology
Finance
Commercial Services

Profil

Sten Gunnar Otto Skolling currently works at Pharmor AB, as Chairman & Chief Executive Officer, Isles of Wines AB, as Chief Executive Officer & Director, Umecrine AB, as Chairman, Chordate Medical Holding AB, as Vice Chairman from 2023, Athera Biotechnologies AB, as Director, Lipidor AB, as Director from 2020, Biochromix AB, as Director, Venture Cup Ost, as Director, Stockholm Biotechbuilders Association, as Director, Nanexa AB, as Director-Business Development, RespiNor AS, as Director, Bactaviva AB, as Director, and Asarina Pharma AB, as Chief Business Officer from 2018.
Mr. Skolling also formerly worked at KCIF Fund Management AB, as Chief Executive Officer, Promimic AB, as Director, Xspray Pharma AB, as Director, Pharmacia Upjohn, as Project Director, Novozymes Biopharma Sweden AB, as Director-Product Pipeline & Business Development, BioChromix Pharma AB, as Non-Executive Director, Umecrine Cognition AB, as Director & Head-Business Development, Limone AB, as Director, NeoDynamics AB, as Director, OssDsign AB, as Director, KD Incentive AB, as Director, Modus Therapeutics Holding AB, as Director, Ziccum AB, as Deputy Director, AB Wilhelm Becker, as Project Manager, Karolinska Development AB (Private Equity), as Vice President from 2012 to 2014, Kabi Pharmacia, as Project Manager, Karolinska Development AB, as Vice President-Portfolio Management from 2007 to 2012, and Inhalation Sciences Sweden AB, as Chief Financial Officer.
Mr. Skolling received his graduate degree from Royal Institute of Technology.

Postes actifs de Sten Gunnar Otto Skolling

SociétésPosteDébut
ASARINA PHARMA AB Public Communications Contact -
NANEXA AB Corporate Officer/Principal 01/01/2015
LIPIDOR AB Director/Board Member 01/01/2020
CHORDATE MEDICAL HOLDING AB Director/Board Member 01/05/2023
Bactaviva AB Director/Board Member -
Isles of Wines AB Chief Executive Officer -
Pharmor AB Chief Executive Officer -
Stockholm Biotechbuilders Association Director/Board Member -
Director/Board Member -
░░░░░░ ░░░░░░░░░░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ -
Tous les postes actifs de Sten Gunnar Otto Skolling

Anciens postes connus de Sten Gunnar Otto Skolling

SociétésPosteFin
░░░░░░░░░░ ░░░░░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░░░░░░ ░░░░░░░░░░░ ░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░░░░░░░ ░░░░░░░░ ░░░░░░ ░░ ░░░░░░░░ ░░ ░░░░░░░░░░░ -
░░░░ ░░░░ ░░░░░░░░░░ ░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ -
Voir l'expérience en détail de Sten Gunnar Otto Skolling

Formation de Sten Gunnar Otto Skolling

Royal Institute of Technology Graduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Sten Gunnar Otto Skolling

Relations

77

Relations au 1er degré

32

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées12
PROMIMIC AB

Health Technology

XSPRAY PHARMA AB

Health Technology

LIPIDOR AB

Commercial Services

ASARINA PHARMA AB

Health Technology

NEOS AB

Health Technology

KAROLINSKA DEVELOPMENT AB

Finance

INHALATION SCIENCES SWEDEN AB

Health Technology

OSSDSIGN AB

Health Technology

MODUS THERAPEUTICS HOLDING AB

Health Technology

NANEXA AB

Health Technology

CHORDATE MEDICAL HOLDING AB

Health Technology

ZICCUM AB

Health Technology

Entreprise privées19

Health Technology

Process Industries

Finance

Health Technology

Kabi Pharmacia

Pharmacia Upjohn

KCIF Fund Management AB

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Venture Cup Ost

KD Incentive AB

Stockholm Biotechbuilders Association

Electronic Technology

Pharmor AB

Isles of Wines AB

Bactaviva AB

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Sten Gunnar Otto Skolling